The influence of Cu2+ on the unfolding and refolding of intact and proteolytically processed β2‐microglobulin

Human β2‐microglobulin (β2m) is an amyloidogenic protein in patients suffering from chronic kidney disease and especially in those patients that need intermittent hemodialysis for longer periods, e.g., when awaiting transplantation. While many in vitro conditions induce β2m‐amyloid formation from wild‐type (wt) β2m and while a number of structurally altered β2m molecules are known to be conformationally unstable and amyloidogenic on their own, it is not known why β2m‐amyloid is generated in some dialysis patients. For many amyloid proteins it is known that divalent metal ions, especially Cu2+, display strong binding and distinct destabilizing effects on protein conformation. The present study uses CE to assess conformational states of wt and cleaved β2m (dK58‐β2m, β2m cleaved at lysine‐58, a modification found in the circulation of hemodialysis patients) in the presence of divalent metal ions. The experiments provide both qualitative and quantitative data showing the specific destabilizing effects of Cu2+‐ions on the folding of wt β2m. Both refolding after acid denaturation and solution structure of β2m under otherwise native conditions are severely influenced by Cu2+. An increased unfolding, aggregation, and induction of Congo red‐reactive molecular species in Cu2+‐incubated wt‐β2m could be demonstrated while the refolding kinetics of dK58‐β2m, already slower than the wt molecule, appeared not to be further decreased by Cu2+. Given the interest in the actions of metal ions in other types of amyloidosis, including, e.g., Alzheimer's disease and the prion encephalopathies, the use of microelectrophoretic methods to monitor unfolding and refolding of biomolecules available in scarce amounts as shown in this study is an attractive option.

[1]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[2]  S. Radford,et al.  Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions. , 2007, Kidney international.

[3]  G. Esposito,et al.  Lysine 58‐cleaved β2‐microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis‐related amyloidosis , 2006, Protein science : a publication of the Protein Society.

[4]  D. B. Corlin,et al.  Variants of β2‐microglobulin cleaved at lysine‐58 retain the main conformational features of the native protein but are more conformationally heterogeneous and unstable at physiological temperature , 2006, The FEBS journal.

[5]  S. Radford,et al.  A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH. , 2006, Biochemistry.

[6]  A. Miranker,et al.  From chance to frequent encounters: origins of beta2-microglobulin fibrillogenesis. , 2005, Biochimica et biophysica acta.

[7]  N. Heegaard,et al.  Interactions of charged ligands with beta(2)-microglobulin conformers in affinity capillary electrophoresis. , 2005, Biochimica et biophysica acta.

[8]  D. B. Corlin,et al.  Quantification of Cleaved β2-Microglobulin in Serum from Patients Undergoing Chronic Hemodialysis , 2005 .

[9]  P. Roepstorff,et al.  Unfolding, aggregation, and seeded amyloid formation of lysine-58-cleaved beta 2-microglobulin. , 2005, Biochemistry.

[10]  R. Vachet,et al.  Using mass spectrometry to study copper-protein binding under native and non-native conditions: beta-2-microglobulin. , 2004, Analytical chemistry.

[11]  A. Miranker,et al.  Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin. , 2004, Biochemistry.

[12]  J. Kardos,et al.  Increase in the conformational flexibility of β2‐microglobulin upon copper binding: A possible role for copper in dialysis‐related amyloidosis , 2004, Protein science : a publication of the Protein Society.

[13]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[14]  A. Miranker,et al.  Formation of a copper specific binding site in non-native states of beta-2-microglobulin. , 2002, Biochemistry.

[15]  P. Roepstorff,et al.  Cleaved β2-Microglobulin Partially Attains a Conformation That Has Amyloidogenic Features* , 2002, The Journal of Biological Chemistry.

[16]  E. Lorenzi,et al.  Capillary electrophoresis investigation of a partially unfolded conformation of β2‐microglobulin , 2002, Electrophoresis.

[17]  C. Dobson,et al.  A Partially Structured Species of β2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis* , 2001, The Journal of Biological Chemistry.

[18]  V. Uversky,et al.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.

[19]  F. Stevens,et al.  Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. , 2001, Journal of molecular biology.

[20]  N. Heegaard,et al.  Conformational Intermediate of the Amyloidogenic Protein β2-Microglobulin at Neutral pH* , 2001, The Journal of Biological Chemistry.

[21]  J. Collinge,et al.  Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Miranker,et al.  Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. , 2001, Journal of molecular biology.

[23]  Jürgen Floege,et al.  β2-Microglobulin–derived amyloidosis: An update , 2001 .

[24]  N. Heegaard,et al.  Congophilicity (Congo red affinity) of different beta2-microglobulin conformations characterized by dye affinity capillary electrophoresis. , 2000, Journal of chromatography. A.

[25]  P. Roepstorff,et al.  Limited proteolysis of β2-microglobulin at Lys-58 by complement component C1s , 1990 .

[26]  J. Pettegrew,et al.  Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  L. Thim,et al.  Purification and biochemical characterization of the complete structure of a proteolytically modified beta-2-microglobulin with biological activity. , 1987, European journal of biochemistry.

[28]  F. Gejyo,et al.  Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. , 1986, The New England journal of medicine.

[29]  B. Frangione,et al.  Beta-2 microglobulin is an amyloidogenic protein in man. , 1985, The Journal of clinical investigation.

[30]  M Arakawa,et al.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.

[31]  D. Warren,et al.  Carpal tunnel syndrome in patients on intermittent haemodialysis , 1975, Postgraduate medical journal.

[32]  D. Brancaccio,et al.  Detection of fragments of β2-microglobulin in amyloid fibrils , 2000 .

[33]  C. Robinson,et al.  Removal of the N‐terminal hexapeptide from human β2‐microglobulin facilitates protein aggregation and fibril formation , 2000, Protein science : a publication of the Protein Society.

[34]  A. Inomata,et al.  Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. , 1992, Nephron.

[35]  D. D. Perrin,et al.  Buffers for pH and metal ion control , 1974 .